Literature DB >> 18375910

Modification of tamoxifen response: what have we learned?

Timothy L Lash, Thomas P Ahern, Deirdre Cronin-Fenton, Jens Peter Garne, Stephen Hamilton-Dutoit, Marianne Ewertz Kvistgaard, Carol L Rosenberg, Rebecca A Silliman, Henrik Toft Sørensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375910     DOI: 10.1200/JCO.2007.15.5432

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

Authors:  Deirdre P Cronin-Fenton; Timothy L Lash
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

2.  CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen.

Authors:  Jean E Abraham; Mel J Maranian; Kristy E Driver; Radka Platte; Bolot Kalmyrzaev; Caroline Baynes; Craig Luccarini; Mitul Shah; Susan Ingle; David Greenberg; Helena M Earl; Alison M Dunning; Paul D P Pharoah; Carlos Caldas
Journal:  Breast Cancer Res       Date:  2010-08-23       Impact factor: 6.466

Review 3.  Genotype-guided tamoxifen therapy: time to pause for reflection?

Authors:  Timothy L Lash; Ernst A Lien; Henrik Toft Sørensen; Stephen Hamilton-Dutoit
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

4.  Comment on 'Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy'.

Authors:  Timothy L Lash; Thomas P Ahern; Deirdre Cronin-Fenton; Jens Peter Garne; Stephen Hamilton-Dutoit; Henrik Toft Sørensen
Journal:  Cancer Sci       Date:  2008-08       Impact factor: 6.716

5.  Improving the transparency of meta-analyses with interactive web applications.

Authors:  Thomas P Ahern; Richard F MacLehose; Laura Haines; Deirdre P Cronin-Fenton; Per Damkier; Lindsay J Collin; Timothy L Lash
Journal:  BMJ Evid Based Med       Date:  2020-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.